Intracranial venous sinus thrombosis occurs in patients with preexisting genetic factors such as factor V Leiden mutations, and acquired thrombophilic conditions such as nephrotic syndrome, infections, drugs, and others (1). In renal transplant recipients, the incidence of thromboembolic phenomena such as deep vein thrombosis is 8%, higher if prothrombotic conditions coexist (2). To the best of our knowledge, cranial venous sinus thrombosis after renal transplantation was previously reported once in the literature and we are reporting here the second case. A 20 year-old female patient presented with a frontal, continuous headache of 6 months duration that was partially relieved by analgesics. There was no associated nausea, vomiting, photophobia, or blurring of vision. She was known to have nephronophthisis, for which she underwent allogenic kidney transplantation from her mother 8 years before her presentation. She also had delayed physical and mental development attributable to her kidney disease. She was on immunosuppressive therapy with prednisone, cyclosporin, and azathioprine, in addition to nifedipine and bisoprolol for blood pressure control. The patient had no personal or family history of thromboembolic events. On physical examination, the patient had normal vital signs, cushingoid features, retrognathia, bilaterally enlarged tonsils, glossoptosis, and normal heart and lung examinations. Her body mass index (BMI) was 29.5 kg/m2. Her fundoscopic examination revealed blurred optic disc margins in the superior and superonasal areas, but no overt papilledema. She had a normal neurological exam except for hyperactive deep tendon reflexes. Her basic metabolic profile was normal and cyclosporin level was 102 ng/mL (normal range: 75–100). Brain magnetic resonance imaging/Magnetic resonance venography (MRI/MRV) revealed partial thrombosis of the junction of left transverse and left sigmoid venous sinuses (Fig. 1). A thrombophilia workup for protein C, protein S, antithrombin III levels, lupus anticoagulant, and factor V Leiden assay was normal. The patient was diagnosed to have a venous sinus thrombosis and was started on acetazolamide and low molecular weight heparin, with glomerullar filtration rate-adjusted doses.FIGURE 1.: Brain MRI. (A) Coronal T2-weighted image of the brain showing absence of normal flow void at the junction of the left transverse and left sigmoid sinuses (arrow). (B). Sagittal enhanced T1-weighted image demonstrating the thrombus within the sigmoid sinus. (C) Brain MRV: Large arrows show the sigmoid sinuses and the one on the left showing absence of flow enhancement; the small arrow show the transverse sinuses patent bilaterally.There is one case report on venous sinus thrombosis in a 49-year-old kidney transplant recipient who presented with headache, had cerebral edema, thrombosis of multiple intracranial venous sinuses associated with toxic cyclosporin levels (2). Our patient had a similar presentation, but was much younger, had a therapeutic cyclosporin level and suffered from a less severe extent of thrombosis. Intracranial venous thrombosis has also been reported in bone marrow transplant patients on methylprednisolone and cyclosporin (3). Renal transplant recipients are predisposed to thromboembolic phenomena. They have deregulation of antithrombin, protein C, protein S, thrombomodulin, fibrinogen, D-dimers, and factor VIII levels (4, 5). They also have impaired release of stimulated endothelial tissue-type plasminogen activator (6). Steroids, cyclosporin, and mycophenolate mofetil, used for immunosuppressive therapy in these patients, contribute by increasing levels of plasminogen activator inhibitor type 1, factor VIII C, fibrinogen, antithrombin III, and protein C, to releasing thromboxane A2 and to enhancing adenosine-5′-diphosphate- induced platelet aggregation (6–10). Finally, renal transplant patients might have alterations in their venous hemodynamics (11). Whatever the mechanism, our case and the one previously reported indicate that venous sinus thrombosis should be considered in the differential diagnosis of kidney transplant patients presenting with unexplained headaches. Zeina Habib Department of Pediatrics American University of Beirut, Medical Center Beirut, Lebanon Chebl Mourani Department of Pediatrics Hotel Dieu de France Hospital Université St. Joseph Beirut, Lebanon Georges Naasan Department of Pediatrics American University of Beirut, Medical Center Beirut, Lebanon Roula Hourani-Rizk Department of Raiology American University of Beirut, Medical Center Beirut, Lebanon Mohamad A. Mikati, MD Department of Pediatrics American University of Beirut, Medical Center Beirut, Lebanon